Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

ETR/IDP stock hub

ETR/IDP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/IDPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

24.3B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/IDP

In the news

Latest news · ETR/IDP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.5

P25 12.3P50 15.7P75 20.2

Trailing P/E20.4

P25 16.4P50 20.9P75 30.4

ROE7.7

P25 -6.7P50 8.5P75 17.2

ROIC10.9

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/IDP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

230

Groups with data

Currency

USD

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	7,500
Employees Change	-105%
Employees Change Percent	-1.38
Enterprise value	EUR 25.8B
Exchange	Deutsche Börse Xetra
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	US09062X1037
Last refreshed	2026-05-10
Market cap	EUR 24.3B
Price	EUR 164
Price currency	EUR
Rev Per Employee	1,149,160.94x
Sector	Healthcare
Sic	2836
Symbol	etr/IDP
Website	https://www.biogen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.9%
EV Earnings	21.69x
EV/EBIT	11.19x
EV/EBITDA	8.35x
EV/FCF	12.28x
EV/Sales	3.06x
FCF yield	8.66%
Forward P/E	13.49x
P/B ratio	1.5x
P/E ratio	20.39x
P/S ratio	2.82x
PE Ratio10 Y	16.99x
PE Ratio3 Y	19.86x
PE Ratio5 Y	19.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	27.32%
EBITDA Margin	35.38%
FCF margin	24.38%
Gross margin	78.72%
Gross Profit	EUR 6.8B
Gross Profit Growth	2.83%
Gross Profit Growth Q	0.78%
Gross Profit Growth3 Y	-0.4%
Gross Profit Growth5 Y	-6.2%
Net Income	EUR 1.2B
Net Income Growth	-7.26%
Net Income Growth Q	32.85%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	-24.05%
Net Income Growth5 Y	-14.55%
Pretax Margin	16.33%
Profit Margin	13.81%
Profit Per Employee	EUR 158,647
Profitable Years	22
ROA	5.9
Roa5y	6.65
ROCE	10.25
ROE	7.7
Roe5y	13.26
ROIC	10.92
Roic5y	13.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-3.32%
Cagr15y	6.33%
Cagr1y	58.68%
Cagr3y	-16.79%
Cagr5y	-6.32%
EPS Growth	-8.1
EPS Growth Q	31.1
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	-24.42
EPS Growth5 Y	-13.58
FCF Growth	-0.57%
FCF Growth Q	167.46%
FCF Growth3 Y	19.25%
FCF Growth5 Y	-5.2%
OCF Growth	0.36%
OCF Growth Q	148.94%
OCF Growth10 Y	-4.25%
OCF Growth3 Y	15.58%
OCF Growth5 Y	-6.01%
Revenue Growth	1.23x
Revenue Growth Q	1.93x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-0.55x
Revenue Growth5 Y	-4.64x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.35
Assets	EUR 25.6B
Cash	EUR 3.7B
Current Assets	EUR 7.8B
Current Liabilities	EUR 2.5B
Debt	EUR 5.7B
Debt EBITDA	EUR 1.8
Debt Equity	EUR 0.35
Debt FCF	EUR 2.71
Equity	EUR 16.2B
Interest Coverage	9.87
Liabilities	EUR 9.4B
Long Term Assets	EUR 17.8B
Long Term Liabilities	EUR 6.9B
Net Cash	EUR -1.6B
Net Cash By Market Cap	EUR -6.48
Net Debt EBITDA	EUR 0.52
Net Debt Equity	EUR 0.1
Net Debt FCF	EUR 0.75
Tangible Book Value	EUR 2.7B
Tangible Book Value Per Share	EUR 18.27
WACC	4.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.06
Inventory Turnover	1
Net Working Capital	EUR 1.7B
Quick ratio	2.03
Working Capital	EUR 5.4B
Working Capital Turnover	EUR 2.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-28.62%
1Y total return	58.63%
200-day SMA	141.4
3Y total return	-42.39%
50-day SMA	158.3
50-day SMA vs 200-day SMA	50over200
5Y total return	-27.83%
All Time High	447.8
All Time High Change	-63.34%
All Time High Date	2015-03-23
All Time Low	29.2
All Time Low Change	462.26%
All Time Low Date	2009-10-26
ATR	3.89
Beta	0.2
Ch YTD	9.49
High	167.2
High52	170.8
High52 Date	2026-02-09
High52ch	-3.88%
Low	161.5
Low52	102
Low52 Date	2025-05-12
Low52ch	60.96%
Ma50ch	3.69%
Price vs 200-day SMA	16.12%
RSI	61.57
RSI Monthly	51.87
RSI Weekly	59.11
Sharpe ratio	1.46x
Sortino ratio	2.55
Total Return	-1.01%
Tr YTD	9.49
Tr15y	151.04%
Tr1m	10.29%
Tr1w	2.63%
Tr3m	-0.04%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 2.4B
Operating Income Growth	4.02
Operating Income Growth Q	-16.14
Operating Income Growth3 Y	-2.11
Operating Income Growth5 Y	-6.25
Operating margin	27.32

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	147,154,881%
Net Borrowing	-251,759,917.8
Shares Insiders	0.2%
Shares Institutions	98.16%
Shares Qo Q	1.16%
Shares Yo Y	1.01%
Short Ratio	3.95

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 1.8B
Average Volume	142.95x
Bv Per Share	109.6
CAPEX	EUR -145.6M
Ch10y	-28.62
Ch15y	151
Ch1m	10.29
Ch1w	2.63
Ch1y	58.63
Ch3m	-0.04
Ch3y	-42.39
Ch5y	-27.83
Ch6m	23.44
Change	1.13%
Change From Open	-0.11
Close	162.3
Days Gap	1.24
Depreciation Amortization	679,302,358.2
Dollar Volume	4,104.5
Earnings Date	2026-04-29
EBIT	EUR 2.4B
EBITDA	EUR 3B
EPS	EUR 8.06
F Score	6
FCF	EUR 2.1B
FCF EV Yield	8.14x
Financing CF	-279,877,710
Fiscal Year End	December
Founded	1,978
Goodwill	5,502,171,029.4
Graham Number	140.80643
Graham Upside	-14.24
Income Tax	EUR 217.8M
Investing CF	-1,329,831,090
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Date	2001-01-18
Last Split Type	Forward
Lynch Fair Value	EUR 40.25
Lynch Upside	-75.48
Ma150	149.6
Ma150ch	9.71%
Ma20	156.3
Ma20ch	5.07%
Net CF	680,310,120
Next Earnings Date	2026-07-29
Open	164.4
P FCF Ratio	11.55
P OCF Ratio	10.8
Position In Range	46.97
Ppne	2,772,157,370.4
Price Date	2026-05-08
Price EBITDA	EUR 7.96
Ptbv Ratio	9
Relative Volume	0.17x
Revenue	8,618,707,020x
SBC By Revenue	2.96x
Share Based Comp	254,812,740
Tax By Revenue	2.53x
Tax Rate	15.47%
Tr6m	23.44%
Volume	25
Z Score	3.12

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ETR/IDP pay a dividend?

Capital-return profile for this ticker.

Performance

ETR/IDP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/IDP?

Insider, institutional, and short-interest positioning.

Institutional ownership

+98.2%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ETR/IDP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.6

Neutral momentum band

Price vs 200-day MA

+16.1%

50/200-day relationship not available

Beta (5Y)

0.20

Less volatile than the market

Sharpe ratio

1.46

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/IDP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/IDP stock rating?

etr/IDP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/IDP analysis?

The full report lives at /stocks/etr/IDP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/IDP?

The latest report frames etr/IDP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/IDP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.